Endogenous

Endogena Therapeutics

This biotech company develops small-molecule regenerative medicines to repair tissues and organs for patients with degenerative eye diseases and genetic disorders.

Endogena

This clinical-stage biotechnology company develops small-molecule regenerative medicines to treat degenerative eye diseases and other conditions for patients with high unmet medical needs.

Satellos Bioscience

This company develops oral small molecule drugs to restore muscle regeneration for patients with Duchenne muscular dystrophy and other degenerative muscle diseases.

Etheros

This company develops small molecule enzyme-mimetic drugs to prevent oxidative and inflammatory injury for patients with neurodegenerative and age-related conditions.

Curegenix

This company develops small-molecule chemical drugs for the treatment of tumours and organ fibrosis for patients with stem cell related diseases.

Endurance Bio

This biotechnology company develops oral small molecule therapeutics for patients with neurodegenerative and metabolic diseases to restore mitochondrial and lysosomal health.

Satellos

This company develops small molecule therapeutics to restore muscle regeneration for patients with Duchenne muscular dystrophy and other degenerative muscle diseases.

Deciduous Therapeutics

This company develops small-molecule immunotherapies that activate the immune system to remove senescent cells for patients with age-related, metabolic and fibrotic diseases.